Evaluation of microbial-derived metabolites in patients with acute pulmonary embolism: findings from the MICTEP study
Open Access
- 24 July 2025
- journal article
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (6)
Abstract
Introduction: Functional analysis of microbiome with microbial-derived metabolites (MDMs) has emerged as key for several inflammatory and cardiovascular diseases. However, the data on the relationship of pulmonary embolism (PE) to microbiome are scarce. This study aimed to compare MDM levels between acute PE patients and healthy controls, and to investigate their associations with predisposing factors ( i.e. unprovoked, provoked and cancer-associated thrombosis). Methods: We collected serum samples from a multicentric cohort, including 96 patients with acute PE at hospital admission and 30 healthy controls. Serum concentrations of MDMs and inflammation/coagulation-related markers were quantified by liquid chromatography–mass spectrometry and flow cytometry, respectively. Results: Compared with healthy controls, patients with acute PE showed significantly higher serum levels of trimethylamine N-oxide (TMAO) (11.5 μM versus 6.7 μM; p=0.02) and acetate (48.3 μM versus 33.0 μM; p=0.04); and lower levels of propionate (3.8 μM versus 5.3 μM; p=0.007), butyrate (4.03 µM versus 7.68 µM; p=0.009), isobutyrate (5.0 μM versus 7.32 μM; p=0.002) and valerate (0.4 μM versus 0.63 μM; p<0.001). Valerate showed the best discrimination between PE and controls (area under the receiver operating characteristic curve 0.758, 95% CI 0.66–0.86). In the multinomial analysis, higher values of TMAO and acetate were associated with a higher probability of unprovoked PE. MDM levels exhibited different correlation with inflammation-related markers highlighting TGF-β1, CCL2 and CXCL10. Conclusion: These findings reveal imbalances in the serological concentrations of MDMs in patients with acute PE and highlight the potential role of the microbiome and its functional metabolites as novel predisposing risk factors for PE.Keywords
Funding Information
- Sociedad Española de Neumología y Cirugía Torácica
- Sociedad Valenciana de Neumología
This publication has 43 references indexed in Scilit:
- Biomarcadores biológicos en las enfermedades respiratoriasArchivos de Bronconeumología, 2022
- Immunomodulatory roles of microbiota-derived short-chain fatty acids in bacterial infectionsBiomedicine & Pharmacotherapy, 2021
- Enfermedad tromboembólica crónica pulmonarArchivos de Bronconeumología, 2020
- The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directionsEBioMedicine, 2020
- Role of gut microbiota in type 2 diabetes pathophysiologyEBioMedicine, 2020
- Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cellsEuropean Journal of Pharmacology, 2018
- Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasomeBiochemical and Biophysical Research Communications, 2016
- Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis RiskCell, 2016
- Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of AtherosclerosisCell, 2015
- Basic mechanisms and pathogenesis of venous thrombosisBlood Reviews, 2009